NKX6-1 and type 2 diabetes mellitus: Collectively, these data demonstrate that NKX6.1 is part of the transcriptional machinery that regulates miR-184-3p expression levels in both human and murine β-cells, thus linking the observed reduction in miR-184-3p to NKX6.1 expression and subcellular localisation in T2D.